Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer



We sought to define the incidence and characterize the timing of hospice utilization among racial/ethnic minority patients following pancreatectomy for pancreatic cancer.


The Medicare Standard Analytic Files from 2013 to 2017 were used to identify patients with pancreatic cancer who underwent a pancreatectomy. Logistic regression was utilized to identify the association between race and patterns of hospice utilization among deceased individuals.


Among the 14,495 individuals (median age 73; 52.3% female; 6.8% racial/ethnic minority) who underwent a pancreatectomy for pancreatic cancer, 47% (n = 6859) died by the end of the follow-period. Among deceased individuals, three-fourths of patients (n = 4978, 72.6%) used hospice leading up to the time of death. Racial/ethnic minority patients were less likely, however, to have used hospice services compared with white patients (racial/ethnic minorities n = 301, 67% vs. whites: n = 4677, 73%; p = 0.024). On multivariable analysis, after controlling for clinical factors, racial/ethnic minority patients remained 22% less likely than whites to initiate hospice services prior to death (OR 0.78, 95% CI 0.63–0.96). Despite overall lower use of hospice, racial/ethnic minority patients had comparable odds of late hospice utilization (i.e., within 3 days of death) versus white patients (OR 1.5, 95% CI 0.73–1.50).


While most patients undergoing pancreatectomy for pancreatic cancer utilized hospice services prior to death, racial/ethnic minorities were less likely to use hospice services than whites.

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Tavakkoli A, Singal AG, Waljee AK, et al. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States. Clin Gastroenterol Hepatol. 2019.

  2. 2.

    Wright MJ, Overton HN, Teinor JA, et al. Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg. 2019.

  3. 3.

    Nipp R, Tramontano AC, Kong CY, et al. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018;7(2):525–535.

    Article  Google Scholar 

  4. 4.

    Cheraghlou S, Gahbauer EA, Leo-Summers L, Stabenau HF, Chaudhry SI, Gill TM. Restricting Symptoms Before and After Admission to Hospice. Am J Med. 2016;129(7):754 e757–754 e715.

    Article  Google Scholar 

  5. 5.

    Organization NHaPC. NHPCO Facts and Figures. 2018. https://www.nhpco.org/wp-content/uploads/2019/07/2018_NHPCO_Facts_Figures.pdf.

  6. 6.

    Paredes AZ, Hyer JM, Tsilimigras DI, et al. Hospice utilization among Medicare beneficiaries dying from pancreatic cancer. J Surg Oncol. 2019;120(4):624–631.

    PubMed  Google Scholar 

  7. 7.

    Taylor JS, Rajan SS, Zhang N, et al. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol. 2017;35(16):1829–1835.

    Article  Google Scholar 

  8. 8.

    Rush B, Hertz P, Bond A, McDermid RC, Celi LA. Use of Palliative Care in Patients With End-Stage COPD and Receiving Home Oxygen: National Trends and Barriers to Care in the United States. Chest. 2017;151(1):41–46.

    Article  Google Scholar 

  9. 9.

    Ferris FD, Bruera E, Cherny N, et al. Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol. 2009;27(18):3052–3058.

    Article  Google Scholar 

  10. 10.

    Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.

    Article  Google Scholar 

  11. 11.

    Iezzoni LI, Daley J, Heeren T, et al. Using administrative data to screen hospitals for high complication rates. Inquiry. 1994;31(1):40–55.

    CAS  PubMed  Google Scholar 

  12. 12.

    Iezzoni LI, Daley J, Heeren T, et al. Identifying complications of care using administrative data. Med Care. 1994;32(7):700–715.

    CAS  Article  Google Scholar 

  13. 13.

    Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB. Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for Medicare beneficiaries. JAMA. 2015;313(5):496–504.

    CAS  Article  Google Scholar 

  14. 14.

    Fairfield KM, Murray KM, Wierman HR, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol. 2012;125(1):14–18.

    Article  Google Scholar 

  15. 15.

    Enomoto LM, Schaefer EW, Goldenberg D, Mackley H, Koch WM, Hollenbeak CS. The Cost of Hospice Services in Terminally Ill Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2015;141(12):1066–1074.

    Article  Google Scholar 

  16. 16.

    Wachterman MW, Hailpern SM, Keating NL, Kurella Tamura M, O'Hare AM. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis. JAMA Intern Med. 2018;178(6):792–799.

    Article  Google Scholar 

  17. 17.

    Zou WY, El-Serag HB, Sada YH, et al. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018;63(5):1173–1181.

    Article  Google Scholar 

  18. 18.

    Kim A, Ashman P, Ward-Peterson M, Lozano JM, Barengo NC. Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013. PLoS One. 2017;12(8):e0183782.

    Article  Google Scholar 

  19. 19.

    Bregar AJ, Alejandro Rauh-Hain J, Spencer R, et al. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis. Gynecol Oncol. 2017;145(1):114–121.

    Article  Google Scholar 

  20. 20.

    Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018;36(1):25–33.

    CAS  Article  Google Scholar 

  21. 21.

    Laquente B, Calsina-Berna A, Carmona-Bayonas A, Jimenez-Fonseca P, Peiro I, Carrato A. Supportive care in pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2017;19(11):1293–1302.

    CAS  Article  Google Scholar 

  22. 22.

    Sheffield KM, Crowell KT, Lin YL, Djukom C, Goodwin JS, Riall TS. Surveillance of pancreatic cancer patients after surgical resection. Ann Surg Oncol. 2012;19(5):1670–1677.

    Article  Google Scholar 

  23. 23.

    Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists : challenges to assuring access to oncology services. J Oncol Pract. 2007;3(2):79–86.

    Article  Google Scholar 

  24. 24.

    Johnson KS, Kuchibhatla M, Tulsky JA. Racial differences in self-reported exposure to information about hospice care. J Palliat Med. 2009;12(10):921–927.

    Article  Google Scholar 

  25. 25.

    Kreling B, Selsky C, Perret-Gentil M, Huerta EE, Mandelblatt JS, Latin American Cancer Research C. 'The worst thing about hospice is that they talk about death': contrasting hospice decisions and experience among immigrant Central and South American Latinos with US-born White, non-Latino cancer caregivers. Palliat Med. 2010;24(4):427–434.

    Article  Google Scholar 

  26. 26.

    Smith AK, Sudore RL, Perez-Stable EJ. Palliative care for Latino patients and their families: whenever we prayed, she wept. JAMA. 2009;301(10):1047–1057, E1041.

    CAS  Article  Google Scholar 

  27. 27.

    Cicolello K, Anandarajah G. Multiple Stakeholders' Perspectives Regarding Barriers to Hospice Enrollment in Diverse Patient Populations: A Qualitative Study. J Pain Symptom Manage. 2019;57(5):869–879.

    Article  Google Scholar 

  28. 28.

    Rickerson E, Harrold J, Kapo J, Carroll JT, Casarett D. Timing of hospice referral and families' perceptions of services: are earlier hospice referrals better? J Am Geriatr Soc. 2005;53(5):819–823.

    Article  Google Scholar 

  29. 29.

    Dover LL, Dulaney CR, Williams CP, et al. Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors. Neuro Oncol. 2018;20(7):986–993.

    Article  Google Scholar 

  30. 30.

    Zuckerman RB, Stearns SC, Sheingold SH. Hospice Use, Hospitalization, and Medicare Spending at the End of Life. J Gerontol B Psychol Sci Soc Sci. 2016;71(3):569–580.

    Article  Google Scholar 

  31. 31.

    Adams CE, Bader J, Horn KV. Timing of Hospice Referral: Assessing Satisfaction While the Patient Receives Hospice Services. Home Health Care Manag Pract. 2009;21(2):109–116.

    Article  Google Scholar 

  32. 32.

    Ramchandran K, Tribett E, Dietrich B, Von Roenn J. Integrating Palliative Care Into Oncology: A Way Forward. Cancer Control. 2015;22(4):386–395.

    Article  Google Scholar 

  33. 33.

    Elsayem A, Swint K, Fisch MJ, et al. Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol. 2004;22(10):2008–2014.

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Timothy M. Pawlik.

Ethics declarations

Disclosure Information

No competing financial interests exist.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Paredes, A.Z., Hyer, J.M., Palmer, E. et al. Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer. J Gastrointest Surg 25, 155–161 (2021). https://doi.org/10.1007/s11605-020-04568-9

Download citation


  • Hospice
  • Racial/ethnic disparities
  • Pancreatic cancer